drugset / Trial / NCT04712799

Nasal Breathing and Physical Capacity

NCT04712799

Phase 4 Unknown 67 enrolled Sorlandet Hospital HF
NaSingle-groupOpen-labelTreatment

Summary

We know that there is a link between disorders in the upper and lower airways, both epidemiologically, patho-physiologically, and therapeutically. What we know less about is the role for the nose and nasal breathing for physical capacity. That goes both for the ability of the average, healthy persons well as for patients with ie. asthma and COPD to perform daily life activities as well as exercise and for top athletes to perform their maximum oxygen demanding activities. Without this knowledge, we cannot make evidence based decisions about to what extent measures to open the nose medically and/or surgically should be considered to improve physical capacity at any level. The aim of the present project is to expand our knowledge in the field for the best of the ordinary man, patients with airway disorders, and athletes.

Timeline

Start
2021-01-13
Primary completion
2024-01-13
Completion
2024-01-13

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxymetazoline Other / unclassified 0.1 mg/ml Intranasal
Subject Oxymetazoline Other / unclassified 0.5 mg/ml Intranasal